BackCyclo Therapeutics Overview

Cyclo Therapeutics Selling, General & Admin

Selling, General & Admin expenses for CYTH.

Quarterly SG&A Expenses

$1.41M
↓ 7.61% YoY

As of Sep 30, 2024

Annual SG&A Expenses (TTM)

$5.31M
↓ 18.32% YoY

Trailing 12 months ending Sep 30, 2024

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin